Cargando…

Lung Cancer Stem Cells

Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapies. Recent data indicates that stem cells situated throughout the airways may initiate cancer formation. These putative stem cells maintain pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pine, Sharon R., Marshall, Blair, Varticovski, Lyuba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850541/
https://www.ncbi.nlm.nih.gov/pubmed/18525120
http://dx.doi.org/10.1155/2008/396281
_version_ 1782294111952306176
author Pine, Sharon R.
Marshall, Blair
Varticovski, Lyuba
author_facet Pine, Sharon R.
Marshall, Blair
Varticovski, Lyuba
author_sort Pine, Sharon R.
collection PubMed
description Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapies. Recent data indicates that stem cells situated throughout the airways may initiate cancer formation. These putative stem cells maintain protumorigenic characteristics including high proliferative capacity, multipotent differentiation, drug resistance and long lifespan relative to other cells. Stem cell signaling and differentiation pathways are maintained within distinct cancer types, and destabilization of this machinery may participate in maintenance of cancer stem cells. Characterization of lung cancer stem cells is an area of active research and is critical for developing novel therapies. This review summarizes the current knowledge on stem cell signaling pathways and cell markers used to identify the lung cancer stem cells.
format Online
Article
Text
id pubmed-3850541
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38505412013-12-12 Lung Cancer Stem Cells Pine, Sharon R. Marshall, Blair Varticovski, Lyuba Dis Markers Other Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapies. Recent data indicates that stem cells situated throughout the airways may initiate cancer formation. These putative stem cells maintain protumorigenic characteristics including high proliferative capacity, multipotent differentiation, drug resistance and long lifespan relative to other cells. Stem cell signaling and differentiation pathways are maintained within distinct cancer types, and destabilization of this machinery may participate in maintenance of cancer stem cells. Characterization of lung cancer stem cells is an area of active research and is critical for developing novel therapies. This review summarizes the current knowledge on stem cell signaling pathways and cell markers used to identify the lung cancer stem cells. IOS Press 2008 2008-05-27 /pmc/articles/PMC3850541/ /pubmed/18525120 http://dx.doi.org/10.1155/2008/396281 Text en Copyright © 2008 Hindawi Publishing Corporation.
spellingShingle Other
Pine, Sharon R.
Marshall, Blair
Varticovski, Lyuba
Lung Cancer Stem Cells
title Lung Cancer Stem Cells
title_full Lung Cancer Stem Cells
title_fullStr Lung Cancer Stem Cells
title_full_unstemmed Lung Cancer Stem Cells
title_short Lung Cancer Stem Cells
title_sort lung cancer stem cells
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850541/
https://www.ncbi.nlm.nih.gov/pubmed/18525120
http://dx.doi.org/10.1155/2008/396281
work_keys_str_mv AT pinesharonr lungcancerstemcells
AT marshallblair lungcancerstemcells
AT varticovskilyuba lungcancerstemcells